Sernova (TSE:SVA) Hits New 1-Year Low – Here’s What Happened

Sernova Corp. (TSE:SVA)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as C$0.13 and last traded at C$0.13, with a volume of 173070 shares changing hands. The stock had previously closed at C$0.13.

Sernova Price Performance

The firm has a market cap of C$43.77 million, a PE ratio of -2.60 and a beta of 0.73. The stock has a 50 day simple moving average of C$0.14 and a two-hundred day simple moving average of C$0.17. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.